Since the parental PLX038 is already in clinical trials, it would be a straightforward path to translate these experiments to trials on human brain tumors; indeed, a trial of PLX038 in MYC-amplified CNS tumors has been initiated (NCT06161519). The gene discussed is MYC; the disease is brain neoplasm.